Showing 1 - 20 results of 56 for search 'Marina V Shestakova', query time: 0.04s Refine Results
  1. 1
    DECLARE-TIMI 58 trial in the context of EMPA-REG OUTCOME and CANVAS

    DECLARE-TIMI 58 trial in the context of EMPA-REG OUTCOME and CANVAS by Marina V. Shestakova

    Published 2019-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Review of the results of the EASYDia international observational study. The effect of dose titration of diabeton MR on the effectiveness of treatment of type 2 diabetes

    Review of the results of the EASYDia international observational study. The effect of dose titration of diabeton MR on the effectiveness of treatment of type 2 diabetes by Natalia Р. Trubitsyna, Marina V. Shestakova

    Published 2019-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies

    Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies by Marina V. Shestakova, Ekaterina A. Yudovich

    Published 2017-08-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Sakharnyy diabet i endotelial'naya disfunktsiya

    Sakharnyy diabet i endotelial'naya disfunktsiya by Ivona Renata Yarek-Martynova, Marina V. Shestakova

    Published 2004-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2

    The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2 by Elena V. Pokrovskaya, Minara S. Shamkhalova, Marina V. Shestakova

    Published 2019-08-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Corrigendum: The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2 (Diabetes mellitus. 2019;22(3). doi: 10.14341/DM10194)

    Corrigendum: The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2 (Diabetes mellitus. 2019;22(3). doi: 10.14341/DM10194) by Elena V. Pokrovskaya, Minara S. Shamkhalova, Marina V. Shestakova

    Published 2019-10-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    A review of insulin lispro for the treatment of patients with type 2 diabetes mellitus

    A review of insulin lispro for the treatment of patients with type 2 diabetes mellitus by Marina V. Shestakova, Svetlana V. Elizarova, Abdul Jabbar

    Published 2016-07-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Nephroprotective potential of glucagon-like peptide-1 receptor agonists

    Nephroprotective potential of glucagon-like peptide-1 receptor agonists by Minara S. Shamkhalova, Igor A. Sklyanik, Marina V. Shestakova

    Published 2020-04-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study)

    The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study) by Ivan I. Dedov, Marina V. Shestakova, Gagik R. Galstyan

    Published 2016-05-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice

    The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice by Galina A. Melnichenko, Marina V. Shestakova, Roman V. Rozhivanov

    Published 2019-06-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Course and treatment of diabetes mellitus in the context of COVID-19

    Course and treatment of diabetes mellitus in the context of COVID-19 by Marina V. Shestakova, Natalya G. Mokrysheva, Ivan I. Dedov

    Published 2020-06-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    The clinical and epidemiological characteristics of hypogonadism in men with type 2 diabetes mellitus

    The clinical and epidemiological characteristics of hypogonadism in men with type 2 diabetes mellitus by Galina A. Mel'nichenko, Marina V. Shestakova, Roman V. Rozhivanov

    Published 2019-12-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Urate-lowering effects of dipeptidyl peptidase-4 inhibitors

    Urate-lowering effects of dipeptidyl peptidase-4 inhibitors by Taras S. Panevin, Olga V. Zhelyabina, Maxim S. Eliseev, Marina V. Shestakova

    Published 2020-12-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Clinical, pathomorphological and immunohistochemical evaluation of tissue repair in diabetic foot ulcers

    Clinical, pathomorphological and immunohistochemical evaluation of tissue repair in diabetic foot ulcers by Alla Y. Tokmakova, Ekaterina L. Zaitseva, Iya A. Voronkova, Marina V. Shestakova

    Published 2018-12-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Classification of diabetes. World Health Organization 2019. What’s new?

    Classification of diabetes. World Health Organization 2019. What’s new? by Irina V. Kononenko, Olga M. Smirnova, Aleksandr Y. Mayorov, Marina V. Shestakova

    Published 2020-12-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Atlas of Diabetes Register in Russian Federation, status 2018

    Atlas of Diabetes Register in Russian Federation, status 2018 by Ivan I. Dedov, Marina V. Shestakova, Olga K. Vikulova, Mikhail А. Isakov, Anna V. Zheleznyakova

    Published 2019-11-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabetes Register, status 2017

    Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabet... by Ivan I. Dedov, Marina V. Shestakova, Olga K. Vikulova, Anna V. Zheleznyakova, Michail А. Isakov

    Published 2018-08-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Type 2 diabetes and prediabetes prevalence in patients with different risk factor combinations in the NATION study

    Type 2 diabetes and prediabetes prevalence in patients with different risk factor combinations in the NATION study by Ekaterina A. Shestakova, Elena Y. Lunina, Gagik R. Galstyan, Marina V. Shestakova, Ivan I. Dedov

    Published 2020-04-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Features of pregnancy after simultaneous pancreas-kidney transplantation in patient with type 1 diabetes mellitus. Case report

    Features of pregnancy after simultaneous pancreas-kidney transplantation in patient with type 1 diabetes mellitus. Case report by Madina I. Yevloyeva, Darya U. Savitskaya, Anastasia S. Severina, Minara S. Shamkhalova, Natalia P. Trubitsyna, Marina V. Shestakova

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Trends in the epidemiology of chronic kidney disease in Russian Federation according to the Federal Diabetes Register (2013–2016)

    Trends in the epidemiology of chronic kidney disease in Russian Federation according to the Federal Diabetes Register (2013–2016) by Minara S. Shamkhalova, Olga K. Vikulova, Anna V. Zheleznyakova, Michail A. Isakov, Marina V. Shestakova, Ivan I. Dedov

    Published 2018-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: